Kilitch Drugs (India) Limited (KILITCH.BO)
INR 317.75
(-0.87%)
INR 317.75
(-0.87%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.54 Billion | 1.38 Billion | 1.12 Billion | 681.28 Million | 491.44 Million | 814.28 Million |
| Cost of Revenue | 923.24 Million | 771.34 Million | 682.53 Million | 381.21 Million | 297.68 Million | 488.34 Million |
| Gross Profit | 620.47 Million | 617.23 Million | 447.05 Million | 300.06 Million | 193.75 Million | 325.93 Million |
| Operating Expenses | 412.42 Million | 473.72 Million | 349.42 Million | 262.56 Million | 208.62 Million | 225.66 Million |
| Selling, General and Administrative Expenses | 412.42 Million | 26.49 Million | 26.82 Million | 28.34 Million | 28.42 Million | 26.78 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 593 Thousand | 2.62 Million | 1.79 Million | 1.67 Million | 801 Thousand |
| Cost and Expenses | 1.33 Billion | 1.24 Billion | 1.03 Billion | 643.77 Million | 506.31 Million | 714.01 Million |
| Operating Income | 208.05 Million | 145.28 Million | 89.85 Million | 36.18 Million | -13.22 Million | 62.48 Million |
| Interest Expense | 59.29 Million | 49.18 Million | 11.98 Million | 7.54 Million | 7.15 Million | 3.79 Million |
| Income Tax Expense | 57.79 Million | 37.31 Million | 34 Million | 13.52 Million | 7.65 Million | 47.56 Million |
| Earnings before Tax | 193.56 Million | 120.14 Million | 96.14 Million | 51.19 Million | 16.07 Million | 85.86 Million |
| Net Income | 146.01 Million | 104.48 Million | 73.67 Million | 36.71 Million | 8.42 Million | 38.29 Million |
| Earnings Per Share Basic | 9.17 | 6.71 | 4.73 | 2.37 | 0.55 | 2.61 |
| Earnings Per Share Diluted | 9.17 | 6.71 | 4.73 | 2.37 | 0.55 | 2.61 |
| Weighted Average Shares Outstanding | 15.92 Million | 15.58 Million | 15.56 Million | 15.47 Million | 15.42 Million | 14.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.92 Million | 15.58 Million | 15.56 Million | 15.47 Million | 15.42 Million | 14.67 Million |
| Gross Margin | 0.40 | 0.44 | 0.40 | 0.44 | 0.39 | 0.40 |
| EBIT Margin | 0.19 | 0.14 | 0.11 | 0.10 | 0.05 | 0.15 |
| Profit Margin | 0.09 | 0.08 | 0.07 | 0.05 | 0.02 | 0.05 |
| EBITDA | 287.42 Million | 206.49 Million | 134.13 Million | 79.84 Million | 45.46 Million | 112.85 Million |
| Earnings Before Tax Margin | 0.13 | 0.10 | 0.08 | 0.05 | -0.03 | 0.08 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 334.51 Million | 1.54 Billion | 448.18 Million | 317.94 Million | 412.02 Million | 365.57 Million |
| Cost of Revenue | 220.91 Million | 923.24 Million | 280.56 Million | 203.1 Million | 202.05 Million | 170.11 Million |
| Gross Profit | 113.6 Million | 620.47 Million | 167.61 Million | 114.84 Million | 209.96 Million | 195.45 Million |
| Operating Expenses | 105.52 Million | 412.42 Million | 106.13 Million | 100.19 Million | 131.93 Million | 141.56 Million |
| Selling, General and Administrative Expenses | 105.52 Million | - | 106.13 Million | 100.19 Million | 97.65 Million | 108.44 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 25.73 Million | 44.78 Million | 4.71 Million | 29.56 Million | 4.89 Million | 5.62 Million |
| Cost and Expenses | 326.43 Million | 1.33 Billion | 386.7 Million | 303.29 Million | 333.99 Million | 311.67 Million |
| Operating Income | 8.07 Million | 208.05 Million | 61.48 Million | 14.65 Million | 78.02 Million | 53.89 Million |
| Interest Expense | 17.31 Million | 59.29 Million | 13.22 Million | 15.98 Million | 15.08 Million | 14.99 Million |
| Income Tax Expense | 15.38 Million | 57.79 Million | 16.16 Million | 10.8 Million | 16.89 Million | 13.92 Million |
| Earnings before Tax | 16.5 Million | 193.54 Million | 52.96 Million | 28.22 Million | 67.83 Million | 44.52 Million |
| Net Income | 13.4 Million | 146.01 Million | 35.94 Million | 29.09 Million | 47.41 Million | 33.57 Million |
| Earnings Per Share Basic | 0.83 | - | 2.24 | 1.81 | 2.95 | 2.15 |
| Earnings Per Share Diluted | 0.83 | - | 2.24 | 1.81 | 2.95 | 2.15 |
| Weighted Average Shares Outstanding | 16.08 Million | 15.92 Million | 16.08 Million | 16.08 Million | 16.08 Million | 15.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.08 Million | 15.92 Million | 16.08 Million | 16.08 Million | 16.08 Million | 15.58 Million |
| Gross Margin | 0.34 | 0.40 | 0.37 | 0.36 | 0.51 | 0.53 |
| EBIT Margin | 0.05 | - | 0.16 | 0.07 | 0.22 | 0.18 |
| Profit Margin | 0.04 | 0.09 | 0.08 | 0.09 | 0.12 | 0.09 |
| EBITDA | 16.58 Million | - | 70.77 Million | 22.79 Million | 91.08 Million | 67.4 Million |
| Earnings Before Tax Margin | 0.02 | 0.13 | 0.14 | 0.05 | 0.19 | 0.15 |
BUVA
POR
300244
SYNT
300033
301188